Perinatal Pandemic (H1N1) 2009 Infection, Thailand
To the Editor: Infection with infl uenza A pandemic (H1N1) 2009 has been reported worldwide following initial identifi cation of the virus in April 2009 (1) . The groups at highest risk for infection or infl uenza-related complications include pregnant women and children (2) . We report a case of pandemic (H1N1) 2009 infection in a newborn whose mother became ill with pandemic (H1N1) 2009 during the perinatal period.
A newborn girl showed signs of respiratory distress. The relevant perinatal history was maternal illness with pandemic (H1N1) 2009 7 days before delivery. The infant, who had a birth weight of 1,560 grams, was delivered by emergency cesarean section after the mother experienced cardiopulmonary failure at the gestational age of 31 weeks. Apgar scores were 9 and 9 at 1 and 5 minutes, respectively. Physical examination at birth showed a premature infant girl with mild subcostal retraction. Oxygen saturation at room air was 91%-99%. Other results of the physical examination were unremarkable.
Initial management included routine care for premature infants. On the basis of the perinatal history, a throat swab specimen was collected for pandemic (H1N1) 2009 testing by PCR and oseltamivir, 6 mg, was administered every 12 hours (4 mg/kg/ day). The specimen obtained from the throat swab was positive for pandemic (H1N1) 2009 by real-time PCR. The infant required oxygen supplementation. At day 2 of life, acute renal failure with an elevated plasma creatinine level of 1.1 mg/dL developed in the infant. Chest radiograph showed minimal pulmonary infi ltrations. She was started on cefotaxime for suspected sepsis. Oseltamivir dosage was adjusted based on the glomerular fi ltration rate estimated by the formula of Schwartz et al. (3) of 10.5 mL/ min/1.73m 2 to 3 mg every 12 hours to complete 10 doses (2 mg/kg/day).
Infection of the patient was confi rmed by real-time reverse transcription-PCR of the throat swab specimen and by a 4× increase in antibodies against the virus by hemagglutination inhibition test (HI). Antibody titers against pandemic infl uenza (H1N1) 2009 by HI with turkey erythrocytes (4) on days 10, 24, and 42 of life were 10, 160, and 320, respectively (Figure) . At day 4 of life, repeated PCR performed on a throat swab specimen was negative for pandemic (H1N1) 2009. Oxygen supplementation was gradually decreased and fi nally discontinued. Her room air oxygen saturation was 95%-98%. Her clinical symptoms gradually improved. Hemoculture was negative after 72 hours. The antimicrobial drugs were given over an 8-day course. Plasma creatinine decreased to 0.9 mg/dL and 0.6 mg/dL at days 6 and 7 of life, respectively. Her average urine output was 2-3 mL/kg/h. She was discharged at the age of 28 days with a body weight of 2,070 grams.
Pregnant women are one of the highest risk groups for infl uenza A infection and infl uenza-associated complications, including increased maternal and perinatal illness and death rates (5). Thus, pregnant women are given fi rst priority to receive infl uenza vaccination. When infl uenza develops in mothers during the perinatal period, newborns can be infected transplacentally during maternal viremia or by respiratory droplets after birth. Transplacental infection of infl uenza A is rare (5), however, and there have been only a few case reports (6,7). Viremia is more frequent and more extensive in pregnant women due to depressed cell-mediated immune response during the pregnancy (8). Our patient was likely infected in utero because she was delivered by cesarean section and was never exposed to her mother, who required intensive cardiopulmonary support at the time of delivery. (The mother died from respiratory failure 7 days after the cesarean section.)
Clinical manifestations in this patient, including respiratory distress and acute renal failure, were nonspe- cifi c. The high plasma creatinine level in the newborn sometimes refl ects the mother's plasma creatinine level (9) . However, kidney function of the mother of the newborn was within normal limits at the time of Caesarean section; plasma creatinine level of 0.7 mg/dL. An elevated plasma creatinine level is observed frequently in premature infants due to immaturity of the kidney tissue and will usually decrease within a few weeks. Oseltamivir was administered with dose adjustment based on the infant's estimated glomerular fi ltration rate. The recommended dose of oseltamivir for glomerular fi ltration rate <30 mL/ min/1.73 m 2 is 2-3 mg/kg/day, based on preliminary data obtained by a National Institutes of Health-funded Collaborative Antiviral Study Group (10) . The success of our management strategy for this case suggests early treatment with oseltamivir can prevent severe illness in newborns with perinatal infl uenza A pandemic (H1N1) 2009 infection.
Bronchial Casts and Pandemic (H1N1) 2009 Virus Infection
To the Editor: In the late 1990s, triple-reassortant infl uenza A viruses containing genes from avian, human, and swine infl uenza viruses emerged and became enzootic in swine herds in North America (1). The fi rst 11 human cases of novel infl uenza A virus infection were reported to the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) from December 2005 through February 2009 (1) . In response to those reports, surveillance for human infection with nonsubtypeable infl uenza A viruses was implemented.
In the spring of 2009, outbreaks of febrile respiratory infections caused by a novel infl uenza A virus (H1N1) were reported among persons in Mexico, the United States, and Canada (2 
